Nutrition, exercise and lifestyle for fatty liver
Lifestyle change is not the "soft" part of MASH treatment — it is the part with the strongest evidence. Here is how much weight loss the liver needs, what to eat and drink, how to exercise, and which popular liver products don't hold up.
Key takeaways
- 5% weight loss reduces liver fat; 7–10% resolves MASH in most people who reach it; ≥10% can regress fibrosis.
- A Mediterranean-style diet, fewer sugar-sweetened drinks and less fructose, and fewer ultra-processed foods help — even before the scale moves.
- 150+ minutes a week of activity, including resistance training, lowers liver fat independent of weight loss.
- With significant fibrosis, no alcohol. Coffee appears protective. "Liver detox" products do not work.
What this means for you
You do not need a perfect diet. You need a sustained calorie deficit, less sugar and alcohol, and regular movement — and, if that isn't enough to reach 7–10% weight loss, a medication that makes it achievable. We'll set the target with you.
How much weight loss matters
The liver is exquisitely responsive to weight loss. In a landmark study of patients with biopsy-proven MASH followed for a year of lifestyle change:
The catch: fewer than 1 in 10 patients reached 10% with lifestyle alone. That is why we treat weight as a medical target — using nutrition and activity first, then GLP-1-based medication or metabolic surgery when needed (see Treatment and W8Experts). Gradual loss is preferred; very rapid loss can transiently worsen liver inflammation.
Sustained weight loss of 7–10%
Grade A · Guideline-supportedDiet, sugar and fructose
- Calories first. A deficit of about 500–1,000 kcal/day is the driver of liver-fat loss, whatever the eating pattern.
- Mediterranean-style eating — vegetables, legumes, whole grains, fish, olive oil and nuts, with little red and processed meat — reduces liver fat and improves insulin sensitivity even without weight loss, and it lowers cardiovascular risk.
- Cut sugar-sweetened drinks and added fructose. Fructose is converted to fat directly in the liver. Sodas, juices, sweetened coffees and energy drinks are the biggest sources. Whole fruit is fine.
- Limit ultra-processed foods and refined carbohydrates.
- Keep protein adequate — especially on GLP-1 therapy, to protect muscle.
- Low-carbohydrate and intermittent-fasting approaches also reduce liver fat when they produce a calorie deficit; choose the pattern you can keep.
Mediterranean-style diet
Grade B · Recommended patternExercise
Exercise lowers liver fat even when weight doesn't change, and it improves insulin sensitivity and cardiovascular fitness. Guidelines suggest 150–300 minutes per week of moderate activity (or 75–150 minutes vigorous), plus resistance training at least twice weekly. Resistance work matters more during weight loss and GLP-1 therapy, to preserve muscle — which is itself a glucose-disposal organ.
Alcohol and coffee
- Alcohol. Alcohol and metabolic dysfunction amplify each other. With F2 fibrosis or higher, abstain completely. With less severe disease, less is better, and no amount is proven safe; binge drinking is particularly harmful. Moderate drinking with metabolic risk is its own category — MetALD.
- Coffee. Regular coffee consumption (about 2–3 cups a day, without sugar-laden add-ins) is consistently associated with less fibrosis and lower liver-cancer risk in observational studies. Reasonable to continue or start; not a treatment.
- Smoking is linked to fibrosis progression and, independently, to cardiovascular disease.
Complete alcohol abstinence with significant fibrosis
Grade A · Guideline-supportedCoffee
Grade C · ObservationalSupplements and myths
Milk thistle (silymarin)
Grade D · Experimental / not advised"Liver detox" and cleanse products
Grade E · No evidenceVitamin E, omega-3 fish oil, and others
Grade C · MixedWhat we know
- Weight loss improves every feature of MASH in a dose-dependent way.
- Mediterranean eating and exercise reduce liver fat beyond weight loss.
- Alcohol worsens fibrosis in MASLD.
What we don't know
- The single best diet — calorie deficit matters more than macronutrient split.
- Whether coffee is causally protective.
- How to help most people keep weight off long term without medication.
Questions to ask your doctor
- What weight-loss target should I aim for, and by when?
- Would a medication help me reach it?
- Is any amount of alcohol safe for my liver?
- Are my supplements safe for my liver?
How we grade evidence. Every intervention carries a plain label — from established, guideline-supported care (A) through moderate (B) and mixed or limited (C) to experimental (D) and insufficient (E). An improvement on a liver biopsy or scan is not the same as fewer cirrhosis cases, heart attacks, or deaths, and we say which we mean.
Real questions we hear about diet and lifestyle.
How much weight do I actually need to lose? Grade A
What the evidence shows
In biopsy-proven MASH, ≥10% weight loss resolved MASH in about 90% and regressed fibrosis in about 45%.
In our practice
We set a target and use medication when lifestyle alone isn't enough to reach it.
Is fruit bad for a fatty liver because of the fructose? Grade B
What the evidence shows
Liver fat production is driven by high-dose added sugars, especially liquid; whole fruit's fiber slows absorption and is associated with better metabolic health.
In our practice
We target sugar-sweetened drinks first — the single highest-yield change for most patients.
Should I be taking milk thistle? Grade D
What the evidence shows
Trials of silymarin are small and inconsistent; guidelines do not recommend it.
In our practice
We'd rather put your effort into weight loss, exercise and, if needed, a proven medication.
References
- Vilar-Gomez E, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149(2):367–378.
- Rinella ME, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797–1835.
- EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492–542.
- Cusi K, et al. AACE clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings. Endocr Pract. 2022;28(5):528–562.
- Ryan MC, et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol. 2013;59(1):138–143.
- Hallsworth K, Adams LA. Lifestyle modification in NAFLD/NASH: facts and figures. JHEP Rep. 2019;1(6):468–479.
- Sanyal AJ, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362(18):1675–1685.
Ready for a plan that gets you to the weight-loss target your liver needs?
Nutrition, activity and — when needed — medication, from endocrinologists who treat MASLD every day.